Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingNov 8, 2023Gynazole-1Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing...Padagis US LLC · D-0081-2024Class IIITerminatedNov 8, 2023Opium TinctureSubpotent DrugEdenbridge Pharmaceuticals, LLC · D-0080-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0079-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0078-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0077-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0076-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0075-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0074-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0073-2024Class IIITerminatedNov 1, 2023VANCOmycin HCI PFLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0072-2024Class IIITerminatedNov 1, 2023VANCOmycin HCI PFLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0071-2024Class IIITerminatedNov 1, 2023Oxytocin syntheticLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0070-2024Class IITerminatedNov 1, 2023Restore Sinus SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0069-2024Class IITerminatedNov 1, 2023ION* Sinus Support Nasal SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0068-2024Class ITerminatedNov 1, 2023ION*Sinus SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0067-2024Class IIIOngoingNov 1, 2023Methotrexate TabletsFailed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.West-Ward Columbus Inc · D-0066-2024Class IITerminatedOct 25, 2023Foscarnet Sodium 2.4mg/0.1 mL solution for injectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0065-2024Class IITerminatedOct 25, 2023Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administrationLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0064-2024Class IITerminatedOct 25, 2023Tropi-PhenLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0063-2024Class IITerminatedOct 25, 2023Lidocaine HCl 4% ophthalmic solutionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0062-2024Class IITerminatedOct 25, 2023Calcium chloride Solution for Intravenous InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0061-2024Class IITerminatedOct 25, 2023TPC DropsLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0060-2024Class IITerminatedOct 25, 2023Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose VialLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0059-2024Class IITerminatedOct 25, 2023Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mLLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0058-2024Class IITerminatedOct 25, 2023Cefuroxime 4mg /0.4 mLLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0057-2024Class IITerminatedOct 25, 2023Moxifloxacin in Balanced Salt SolutionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0056-2024Class IITerminatedOct 25, 2023Tropi-PhenLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0055-2024Class IITerminatedOct 25, 2023Calcium Gluconate 2.5% solution for inhalationLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0054-2024Class IITerminatedOct 25, 2023Calcium Gluconate Ophthalmic Irrigation Solution 1%Lack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0053-2024Class IITerminatedOct 25, 2023Endophth KitLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0052-2024Class IITerminatedOct 25, 2023Vancomycin 1 MG/0.1 ML Solution for Intraocular InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0051-2024Class IITerminatedOct 25, 2023Bevacizumab 1.25 MG/0.05 ML Solution for InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0050-2024Class ITerminatedOct 25, 2023Betaxolol TabletsPresence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.KVK-Tech, Inc. · D-0049-2024Class IITerminatedOct 25, 2023Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mLCGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.Baxter Healthcare Corporation · D-0048-2024Class ITerminatedOct 25, 2023Sucralfate Oral SuspensionMicrobial Contamination of Non-Sterile Products: identified as Bacillus cereus.VistaPharm LLC · D-0047-2024Class IOngoingOct 25, 2023TheraBreath for Kids! Oral RinseMicrobial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosisChurch & Dwight Inc · D-0046-2024Class IIOngoingOct 25, 2023Certain Over-The-CounterCGMP Deviations: OTC products were stored outside of labeled temperature requirements.Dollar Tree Distribution, Inc. · D-0045-2024Class IIITerminatedOct 25, 2023Bupropion Hydrochloride Extended-Release Tablets USPFailed Dissolution SpecificationsSun Pharmaceutical Industries Inc · D-0044-2024Class IIITerminatedOct 25, 2023MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1%...Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.Imprimis NJOF, LLC · D-0043-2024Class ICompletedOct 18, 2023BREXAFEMMECross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).Scynexis, Inc. · D-0042-2024

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.